HEMORGANIC
HEMORGANIC financials
- Market cap
- ₹5 Cr
Quarterly results
Q1 FY27: net profit up 22.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 2 | 0 | 0 | 0 | 1 −61% | 0 |
| EBITDA | -0 | -0 | 0 | -0 | -0 +50% | -0 +38% | -0 −300% | -0 +36% |
| Net profit | -0 | -0 | 0 | -0 | -0 +63% | -0 −100% | -1 −238% | -0 +22% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +77.6% 1Y
1Y: ₹10.65 on 5 Sept 2025 → ₹18.91. High ₹24.42 (14 Jul 2026), low ₹8.12 (17 Oct 2025).
Financials, as filed
Revenue grew 581.9% a year over 2 years, FY24 to FY26. Operating margin widened to -53.8%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹0 Cr | ₹2 Cr | ₹1 Cr |
| Operating profit | ₹-0 Cr | ₹-0 Cr | ₹-0 Cr |
| Operating margin | -1200.0% | -0.4% | -53.8% |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹-0 Cr | ₹0 Cr | ₹-1 Cr |
| Net margin | -1300.0% | 8.7% | -84.9% |
| Cash from operations | ₹-1 Cr | ₹-0 Cr | ₹-1 Cr |
| Free cash flow | ₹-1 Cr | ₹-0 Cr | ₹-1 Cr |
| ROCE | -52.2% | 2.6% | -23.8% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Reserves | ₹-3 Cr | ₹-3 Cr | ₹-4 Cr | ₹-4 Cr | ₹-4 Cr | ₹-3 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr |
| Other liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr | ₹2 Cr |
| Total liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹5 Cr | ₹4 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹5 Cr | ₹4 Cr |
| Total assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹5 Cr | ₹4 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count shrank 8% to 4,821.
- Promoters
- 16.9%
- Public
- 83.2%
Since Jun 2025
- Public +0.01 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 16.9%, Public 83.2%.Dec '23: Promoters 16.9%, Public 83.2%.Mar '24: Promoters 16.9%, Public 83.2%.Jun '24: Promoters 16.9%, Public 83.2%.Sep '24: Promoters 16.9%, Public 83.2%.Dec '24: Promoters 16.9%, Public 83.2%.Mar '25: Promoters 16.9%, Public 83.2%.Jun '25: Promoters 16.9%, Public 83.2%.Sep '25: Promoters 16.9%, Public 83.2%.Dec '25: Promoters 16.9%, Public 83.2%.Mar '26: Promoters 16.9%, Public 83.2%.Jun '26: Promoters 16.9%, Public 83.2%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Dave Pradip Bharatbhai newly disclosed 1.65% held
- Ayush Dharmendrabhai Jasani newly disclosed 1.58% held
The same filing shows 2 holders trimming and 2 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of HEMORGANIC above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Dineshbhai Shanabhai Patel | 15.49% | unchanged |
| Mitalben Rupeshbhai Desai | 3.49% | unchanged |
| Rupesh Ramanlal Desai | 3.49% | unchanged |
| Mansukhlal Chhotalal Shah | 2.51% | unchanged |
| Ruchira Goyal - 2 | 2.11% | −0.09 pp |
| Rajput Vishal | 1.78% | −0.51 pp |
| Sagar Sheth | 1.78% | unchanged |
| Vijay Bhikhabhai Sheth | 1.72% | unchanged |
| Sangitaben Vijaykuamr Sheth | 1.71% | unchanged |
| Dave Pradip Bharatbhai | 1.65% | newly disclosed |
| Ayush Dharmendrabhai Jasani | 1.58% | newly disclosed |
| Mohammed Fasihuddin | 1.50% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse HEMORGANIC
Guides on how to read this kind of business and the numbers that matter.